Cargando…
Desloratadine Therapy Improves Allergic Rhinitis Symptoms in Latin American Children Aged 6 to 12 Years
OBJECTIVE: To determine the effectiveness of desloratadine syrup in relieving symptoms of allergic rhinitis (AR) among children in Latin America. METHODS: In an open-label trial conducted in 5 Latin American countries, 455 children aged 6 to 12 years with seasonal or perennial AR were treated with d...
Autores principales: | Tassinari, Paolo, Suárez, Nelson R, Centeno, Jorge, Velásquez, Janina Vergara, Aguirre-Mariscal, Héctor, González Díaz, Sandra N, de Córdova Jerves, Alfredo Fernández |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650984/ https://www.ncbi.nlm.nih.gov/pubmed/23282979 http://dx.doi.org/10.1097/WOX.0b013e31819cdfdb |
Ejemplares similares
-
24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]
por: Salmun, Luis M, et al.
Publicado: (2002) -
Treatment of Allergic Rhinitis With Desloratadine: Results of a Multinational Observational Study in the Middle East Gulf Region
por: Adham, Tamer MH
Publicado: (2011) -
Control of allergic rhinitis in four latin american countries: Rinola study
por: Silva, Diana L, et al.
Publicado: (2022) -
Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971].
por: Haye, Rolf, et al.
Publicado: (2005) -
Association between desloratadine and prednisolone in the treatment of children with acute symptoms of allergic rhinitis: a double-blind, randomized and controlled clinical trial()
por: Wandalsen, Gustavo F., et al.
Publicado: (2016)